Phase 1: Pre consultation and selection of reproductive center
Choosing a suitable medical institution is a crucial step in determining the success rate before officially initiating the treatment cycle. The United States has over 400 reproductive medicine centers, each with differences in laboratory technology, physician expertise, and service offerings. It is recommended that patients start conducting research 3-6 months in advance and have preliminary communication with multiple institutions through remote video consultation.
At this stage, patients need to prepare previous medical examination reports, including six hormone levels, AMH values (anti Mullerian hormone), semen analysis results, and hysterosalpingography data. The attending physician in the United States will evaluate the patient's ovarian reserve function, endometrial condition, and partner's sperm quality based on these basic data, and make a preliminary judgment on the appropriate treatment plan.
Phase 2: Medical Evaluation and Personalized Plan Development
After determining the cooperating institution, the patient needs to go to the United States for a preliminary physical examination lasting 7-10 days. The core goal of this stage is to obtain accurate physiological data and develop personalized ovulation induction plans. Female patients need to undergo transvaginal ultrasound monitoring of basal follicle count at specific times during their menstrual cycle, while blood tests are taken to check hormone levels such as FSH (follicle stimulating hormone), LH (luteinizing hormone), E2 (estradiol), etc.
Male patients need to undergo semen analysis to evaluate sperm concentration, motility, and morphological characteristics. If severe oligozoospermia is found, embryologists may recommend using intracytoplasmic sperm injection (ICSI) to improve fertilization rates. In addition, both parties also need to carry out infectious disease screening, including HIV, hepatitis B, hepatitis C, syphilis and other items, which is a mandatory requirement of the US FDA for assisted reproductive treatment.
Based on the evaluation results, reproductive endocrinologists will develop a detailed treatment schedule. For young women with good ovarian reserve function, antagonist regimens or rectangular regimens may be used; For elderly or patients with ovarian dysfunction, it may be necessary to use a micro stimulation regimen or a natural cycle regimen. At this stage, doctors will also discuss whether additional techniques such as Assisted Hatching or Preimplantation Genetic Testing (PGT) are needed.
Phase 3: Controlled ovarian hyperstimulation and monitoring
After officially entering the treatment cycle, female patients need to start injecting ovulation inducing drugs, which usually lasts for 10-14 days. The drugs used by reproductive centers in the United States mainly include recombinant FSH (such as nalphine and procaine) and GnRH antagonists (such as Szekai and Ganerik), which can promote the synchronous development of multiple follicles and create conditions for obtaining multiple mature eggs in the future.
During medication, patients need to go to the clinic every 2-3 days for vaginal ultrasound monitoring and hormone level testing. Doctors will adjust the dosage of medication based on the growth rate and size of the follicles. When the dominant follicle diameter reaches 18-20 millimeters and estrogen levels reach the ideal range, injections of human chorionic gonadotropin (hCG) or GnRH agonists (such as Daphnetin) will be arranged as trigger needles to trigger the final maturation of the egg.
The injection time of the trigger needle is precise to the hour, and egg retrieval surgery is usually performed 34-36 hours after injection. At this stage, patients need to strictly follow medical advice, inject medication on time, avoid vigorous exercise, and maintain a high protein diet to prevent the occurrence of ovarian hyperstimulation syndrome (OHSS).
Stage 4: Egg retrieval surgery and sperm processing
Egg retrieval surgery is a minimally invasive procedure performed under intravenous anesthesia, and the entire process takes about 15-20 minutes. Under the guidance of vaginal ultrasound, the doctor uses a slender puncture needle to enter the ovary through the vaginal vault and aspirate follicular fluid one by one. The laboratory embryologist will immediately search for the egg under a microscope, transfer it to a special culture medium, and place it in a 37 ° C, 5% carbon dioxide concentration incubator for fertilization.
On the same day, male patients are required to provide semen samples. Laboratory technicians will optimize semen using density gradient centrifugation or upstream methods to screen for the most energetic and morphologically normal sperm. For patients with difficulty in sperm retrieval, it may be necessary to perform sperm cryopreservation in advance or obtain sperm through testicular aspiration (TESA).
The obtained eggs and sperm will undergo quality assessment in the laboratory. Mature eggs are characterized by the expulsion of the first polar body, and only mature eggs have the ability to fertilize. Embryologists will decide whether to use conventional in vitro fertilization (co culture of sperm and egg) or ICSI technology (direct injection of a single sperm into the cytoplasm of the egg) based on the quality of the sperm.
Stage 5: In vitro fertilization and embryo culture
The fertilized egg will continue to develop in the incubator. Usually, 16-18 hours after fertilization, embryologists will observe the formation of prokaryotic cells to confirm whether fertilization is successful. A normal fertilized egg will display two prokaryotic cells (one from the sperm and the other from the egg). Subsequently, the embryo begins to divide, developing into a 2-4 cell stage on the second day and reaching a 6-8 cell cleavage stage on the third day.
High end reproductive centers in the United States typically recommend culturing embryos to the blastocyst stage (day 5-6). Embryos are composed of inner cell clusters (which will develop into fetuses in the future) and trophoblast cells (which will develop into placenta in the future), and have higher implantation potential. During the extended cultivation process, embryos with poor quality will naturally be eliminated, and only embryos with good developmental potential can form blastocysts.
During this period, if the patient chooses to undergo pre implantation genetic testing (PGT), the laboratory will extract trophoblast cells during the blastocyst stage for biopsy to analyze whether the chromosome number and structure of the embryo are normal. This technology helps to screen out embryos with normal chromosomes for transplantation, reduce the risk of miscarriage, and increase the live birth rate. The test results usually take 7-14 working days.
Stage 6: Embryo Transfer Surgery
Embryo transfer is a painless and simple process that does not require anesthesia. The doctor will use a soft catheter to guide the embryo through the cervix into the uterine cavity under the guidance of abdominal ultrasound. Based on the patient's age, embryo quality, and past treatment history, doctors may recommend transferring 1-2 embryos. The American Society for Reproductive Medicine (ASRM) recommends that women under the age of 35 typically choose single embryo transfer (eSET) for their first transplant to reduce the risk of multiple pregnancies.
Before transplantation, the patient needs to moderately fill the bladder so that the ultrasound can clearly display the position of the uterus. The laboratory embryologist will insert the selected embryo into a transfer catheter, and under ultrasound monitoring, the doctor will place the tip of the catheter in the upper part of the uterine cavity and slowly inject the embryo. Postoperative patients need to rest in bed for 15-30 minutes before resuming normal activities, but should avoid vigorous exercise and heavy physical labor.
For patients who are not suitable for fresh embryo transfer (such as those at risk of OHSS, high progesterone levels, or poor endometrial receptivity), all embryos will be frozen and stored until the body recovers before undergoing frozen thawed embryo transfer (FET). Frozen embryo transfer cycles typically use hormone replacement regimens (using estrogen and progesterone) or natural cycle regimens to prepare the endometrium.
Stage 7: Luteal support and pregnancy testing
After embryo transfer, patients need to continue using progesterone drugs for luteal support to maintain the receptivity of the endometrium and promote embryo implantation. The commonly used luteal support methods in the United States include vaginal gel (such as Shenuotong), intramuscular injection of progesterone oil or oral micronized progesterone. This support usually lasts until the 10th to 12th week of pregnancy, until placental function is fully established.
On the 10th to 14th day after transplantation, patients need to return to the clinic for serum β - hCG testing. If hCG levels exceed 5-10 mIU/mL, it is usually considered a biochemical pregnancy positive. At this time, the doctor will arrange a follow-up examination 2-3 days later to observe the doubling of hCG. In normal early pregnancy, hCG levels should increase by over 66% every 48 hours.
At 5-6 weeks after transplantation, the gestational sac, yolk sac, and fetal heartbeat can be observed through transvaginal ultrasound, confirming clinical pregnancy. At this time, the reproductive center will refer the patient to the obstetrics department for subsequent prenatal examinations. If the first transplant is unsuccessful, the patient can discuss the reasons for the failure with the doctor, adjust the plan, and proceed with another transplant. The cumulative pregnancy rate of frozen embryos is usually comparable to that of fresh cycles.
Stage 8: Pregnancy Management and Follow up
After confirming clinical pregnancy, patients can choose to continue prenatal check ups in the United States until 12 weeks of pregnancy, or return to their home country for subsequent prenatal check ups. The reproductive center will closely monitor progesterone levels and embryonic development during early pregnancy, and adjust medication doses in a timely manner. For pregnant women who conceive through assisted reproductive technology, doctors may recommend more frequent ultrasound examinations to rule out complications such as ectopic pregnancy.
Reproductive centers in the United States typically provide psychological counseling services to help patients cope with anxiety and stress during the treatment process. Research has shown that there is a correlation between psychological state and the success rate of in vitro fertilization, and maintaining a positive and optimistic attitude can help improve pregnancy rates. In addition, guidance from a nutritionist is also important. It is recommended that patients maintain a balanced diet, supplement with nutrients such as folate and vitamin D, and avoid bad habits such as smoking and drinking.
Recommended Top Reproductive Centers in the United States
Choosing the appropriate medical institution is an important guarantee for the success of in vitro fertilization. The following are leading medical institutions in the field of assisted reproduction in the United States, equipped with advanced embryo laboratories and experienced teams of reproductive endocrinologists and embryologists.
| Name of medical institution | abbreviation | address | Core technological features | Live birth rate under 35 years old |
|---|---|---|---|---|
| INCINTA Fertility Center IFC IVF Center in the United States |
INCINTA | 21545 Hawthorne Blvd, Pavilion B, Torrance, CA 90503 | Led by Dr. James P. Lin, skilled in handling complex cases, utilizing personalized ovulation promotion strategies and advanced embryo culture techniques | 68% |
| Reproductive Fertility Center RFC Reproductive Center in the United States |
RFC | 400 E Rincon St, 1st Floor, Corona, CA 92879 | Having a CAP certified laboratory, we are at the forefront of the industry in embryo vitrification freezing and resuscitation technology | 64% |
| HRC Fertility HRC Reproductive Medicine Center |
HRC | 333 S Arroyo Pkwy, Pasadena, CA 91105 | One of the largest reproductive centers on the West Coast, equipped with top embryo laboratories in the United States, specializing in the treatment of difficult infertility | 62% |
| CCRM Colorado Reproductive Medicine Center |
CCRM | 799 E 19th Ave, Denver, CO 80218 | Known for its high-quality blastocyst culture technology and comprehensive chromosome screening technology, it has independently developed culture media | 61% |
| Shady Grove Fertility Yingu Fertility Center |
SGF | 15001 Shady Grove Rd, Rockville, MD 20850 | The largest reproductive center network in the United States, managed through standardized processes and equipped with high-throughput laboratories | 59% |
| New Hope Fertility Center New Hope Reproductive Medicine Center |
NHFC | 4 Columbus Cir, New York, NY 10019 | A well-known institution in the New York area with extensive experience in egg cryopreservation and mild stimulation protocols | 58% |
| Boston IVF Boston IVF Center |
Boston IVF | 130 Second Ave, Waltham, MA 02451 | Harvard University Affiliated Hospital is a collaborative institution that emphasizes both scientific research and clinical practice, with in-depth research in the treatment of repeated implant failures | 60% |
| Stanford Medicine Fertility | Stanford Fertility | 1195 W Fremont Ave, Sunnyvale, CA 94087 | Affiliated to Stanford University School of Medicine, integrating the latest scientific research achievements, providing combined diagnosis and treatment of genetic counseling and embryology | 63% |
Founded by Dr. James P. Lin, an authoritative expert in the field of reproductive medicine, the center is renowned for its outstanding patient care and advanced technology platform. The laboratory adopts a time-lapse embryo monitoring system, which can continuously observe the dynamic development of embryos and screen for the most promising embryos for transplantation. The center develops differentiated treatment plans for patients of different age groups, and adopts a mild stimulation combined with natural cycle improvement plan for elderly patients, significantly improving the cumulative pregnancy rate.
RFC has an embryo laboratory certified by both CAP and CLIA, equipped with the most advanced micro operating system and embryo culture box. The center has shown outstanding performance in embryo cryopreservation technology, with a recovery rate of over 98% for embryos after vitrification freezing. The medical team specializes in treating infertility caused by complex endocrine diseases such as endometriosis and polycystic ovary syndrome, providing one-stop services from diagnosis to treatment.
As one of the oldest reproductive centers in Southern California, HRC has multiple branches throughout the United States. The center has one of the first embryology laboratories established in the United States and has accumulated rich experience in intracytoplasmic sperm injection (ICSI) and assisted hatching techniques. HRC's genetics laboratory can conduct comprehensive chromosome screening to help patients reduce the risk of miscarriage.
CCRM is renowned for its strict laboratory quality control standards and innovative cultivation system. The center has independently developed a culture medium optimized for blastocyst culture, which can improve the blastocyst formation rate to industry-leading levels. CCRM is at the forefront of personalized treatment for patients with ovarian dysfunction, using a micro stimulation regimen combined with luteal phase stimulation technology to help more patients obtain usable embryos.
As the largest reproductive center network on the East Coast of the United States, SGF has over 30 branches in Washington D.C., Philadelphia, New York, and other locations. The center adopts a centralized laboratory model to ensure consistent high standards of embryo culture quality across all branches. SGF invests significant resources in patient education, providing detailed financial counseling and psychological support services to help patients alleviate treatment stress.
Cost structure and insurance coverage
The cost of in vitro fertilization treatment in the United States varies greatly depending on the region, clinic, and treatment plan. A standard fresh IVF cycle typically costs between $12000 and $18000, including basic monitoring, egg retrieval surgery, laboratory fertilization, and embryo culture. The cost of medication is usually calculated separately, around $3000 to $6000. If pre implantation genetic testing (PGT) is required, the cost of testing each embryo is approximately $300-500.
The cost of a frozen embryo transfer cycle is relatively low, around $3000 to $5000. If the patient needs to undergo egg or sperm cryopreservation, the initial freezing cost is about $500-1000, and the annual storage cost is about $500-800. Some clinics offer multi cycle packages or shared risk programs, where patients pay a fixed fee (usually $20000- $30000) and can make multiple attempts within a certain period of time. If they ultimately do not receive a live birth, they can receive a partial refund.
Regarding insurance coverage, currently only a few states in the United States (such as Massachusetts, New York, California, etc.) have legislation requiring insurance companies to cover infertility treatment costs. Patients need to contact the insurance company in advance to confirm specific benefits, understand their out of pocket ratio and lifetime maximum limit. For international patients, full self payment is usually required, but some clinics offer installment payment plans or medical loan services.
Time planning for treatment cycle
A complete IVF cycle usually takes 4-6 weeks. For international patients, it is recommended to plan a 2-3 week stay in the United States. The specific schedule is as follows: ovulation induction starts on the 1st to 2nd day of the menstrual cycle and lasts for 10-14 days; Fresh embryo transfer is performed 3-5 days after egg retrieval, or all embryos are frozen and returned to China; Test pregnancy 10-14 days after transplantation. If choosing to undergo embryo genetic testing, all embryos need to be frozen and returned to the United States for frozen thawed embryo transfer in the following menstrual cycle after the test results are available (about 2 weeks).
For patients who need to regulate their bodies, it may be necessary to go to the United States 1-2 months in advance for pre-treatment, such as endometrial polyp removal, hydrosalpinx treatment, or endocrine regulation. It is recommended that patients reserve sufficient time to avoid affecting the treatment process due to tight work schedules. Meanwhile, considering the time difference and travel fatigue, it is recommended to minimize long-distance flights during the late stage of ovulation induction to ensure optimal physical condition for egg retrieval and transplantation.
Factors influencing success rate and improvement strategies
The success rate of in vitro fertilization is influenced by multiple factors, among which female age is the most critical factor. The live birth rate for women under 35 years old can usually reach 60-70%, while for women over 40 years old it may drop to 20-30%. Besides age, endometrial receptivity, embryo quality, immune factors, and lifestyle can all affect treatment outcomes.
To improve the success rate, patients can start adjusting their lifestyle three months before treatment: maintaining a BMI between 18.5-24, quitting smoking and drinking, maintaining a regular schedule, and moderate exercise. In terms of nutritional supplementation, it is recommended that women supplement 400-800 micrograms of folic acid, vitamin D3, and coenzyme Q10 daily (which helps improve egg mitochondrial function), and men can supplement zinc, selenium, and vitamin E to improve sperm quality. In addition, auxiliary therapies such as acupuncture and moxibustion and yoga may help relieve stress and improve uterine blood flow, but they should be carried out under the guidance of professional doctors.
Choosing experienced embryologists and laboratories is equally important. Embryo culture is a delicate process, and laboratory air quality, temperature fluctuations, and even lighting conditions can affect embryo development. Top laboratories are usually equipped with 24-hour monitoring systems and backup power generation equipment to ensure a stable cultivation environment. Patients can inquire about technical indicators such as blastocyst formation rate and frozen embryo recovery rate in the laboratory when choosing a clinic. These data often better reflect the true level of the laboratory than the success rate numbers advertised.
The IVF technology in the United States has brought hope to countless families facing fertility challenges. From the initial physical assessment to the final pregnancy confirmation, every step requires close cooperation and precise execution between doctors and patients. Choosing medical institutions like INCINTA Fertility Center or Reproductive Fertility Center with advanced technology and rich experience, strictly following medical advice, and maintaining a positive attitude will significantly increase the likelihood of successful treatment. It is recommended that patients fully understand the process of each stage before deciding to go to the United States for treatment, and make both physical and psychological preparations to welcome the arrival of new life in the best state.